We are looking forward to the Bleddyn Rees’ session at the FH Europe conference on the 6th September in Prague organised under the auspices of Czech Republic Presidency of the European Union.
FH Europe is the European FH Patient Network. FH (Familial Hypercholestrolaemia) is an inherited, very high cholesterol and effects 1:300 individuals regardless of their age, race, sex and lifestyle.
The conference is focussed on “Paediatric screening – moving prevention from evidence to action. Overcoming the barriers to implementation.
This event will convene thought leaders from across different sectors. It will look beyond the technical questions about FH paediatric screening that have dominated the screening debate thus far. International experts will explore specific barriers (science, funding, healthcare systems, behaviour) which are hampering the implementation of screening and how these barriers may be overcome to secure universal implementation of inherited high cholesterol screening – a solution to beating cardiovascular diseases (CVD) and building cardiovascular health (CVH) across Europe.